ADVERTISEMENT

The Nexus Between Sun Pharma, Aditya Medisales And Dilip Shanghvi

BloombergQuint’s investigation finds Sun Pharma’s disclosure on a related party came several years late.

Dilip Shanghvi, chairman of Sun Pharmaceutical Industries Ltd., poses during an interview at the company’s headquarters in Mumbai. (Photographer: Kuni Takahashi/Bloomberg)
Dilip Shanghvi, chairman of Sun Pharmaceutical Industries Ltd., poses during an interview at the company’s headquarters in Mumbai. (Photographer: Kuni Takahashi/Bloomberg)
In December a whistleblower letter and a brokerage sales note cast several doubts about disclosure and corporate governance standards at Sun Pharmaceutical Industries Ltd. Among those is the relationship between its Promoter and Managing Director Dilip Shanghvi and one of the company’s key distributors – Aditya Medisales Ltd. A BloombergQuint investigation shows this relationship went back several years and ought to have been disclos...
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More